StrideBio
Matthew Self has four years of work experience. In 2021, they began working as Lead Vector Production Specialist at StrideBio, Inc. Prior to that, they worked as Manufacturing Specialist II at Medicago from 2020 to 2019. From 2019 to 2016, they were a Bioprocess Technician III at FUJIFILM Diosynth Biotechnologies. Before that, they were a Senior Technician at Merck from 2016.
Matthew Self attended North Carolina State University from 2006 to 2011, studying Chemical Engineering.
This person is not in any teams
This person is not in any offices
StrideBio
1 followers
StrideBio, Inc. is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies.